You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas
Telix and Ekalia to develop US astatine-211 production
Login
Username:

Password:


Related Headlines

Oracle partners AstraZeneca for AI-enabled healthcare innovation

Telix and Ekalia to develop US astatine-211 production

AbbVie's dual-targeting Crohn's disease therapy outperforms monotherapies in Phase IIa trial

Takeda trial shows ENTYVIO reduces ulcerative colitis complication risk by nearly 70%

GSK reports 61% response rate for investigational lung cancer drug

Omeros receives negative EU opinion on narsoplimab after re-examination

VibroSense Dynamics secures Thai regulatory approval for VibroSense Meter II

IBA and Framatome establish joint venture to scale up Astatine-211 production

Expression Therapeutics awarded USD2m grant to advance potential new therapy for children with high-risk neuroblastoma

Medtronic confirms separation of MiniMed

SenderraRx receives reaccreditation in Specialty Pharmacy from ACHC

EMA issues positive CHMP opinion for Revolution Medicines' RASONQUE in metastatic pancreatic cancer

Philips-led EXIT-CVD consortium launches cardiovascular clinical studies across Europe

SciBase technology selected as primary endpoint in NIH-led skin exposure study

Continuity Biosciences awarded Gates Foundation grant to advance ultra-long-acting implant for HIV prevention

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026